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Tobacco smoke may be one of the most common sources of cadmium (Cd) in the general population, 
particularly in the rising population of smokers in developing countries. Although a relationship between both 
cigarette smoking and environmental Cd contamination with prostate cancer exist, the mechanisms are unclear. 
Most prospective cohort studies found a positive association between current smoking and a fatal cancer of the 
prostate. We investigated the interaction between zinc and cadmium and the potential risk of prostate cancer in 
smokers.  Serum cadmium level was significantly (P<0.001) higher in smokers compared with non-smokers, the 
level in smokers was three-fold that in non-smokers.  In contrast zinc was significantly (P<0.001) reduced in 
smokers compared with non-smokers. Unlike Zn, Cu was significantly (P<0.05)  higher in smokers than in non-
smokers. Iron (Fe) though higher in smokers was not significantly different. Zinc: cadmium ratio was very 
significantly (P<0.001) reduced, implying high cadmium: zinc ratio. This ratio was 4.5-fold the level in non-
smokers. Total protein, albumin and total globulin levels were all significantly (P<0.001) reduced in smokers 
compared with non-smokers respectively. Potassium (K
+
) was significantly (P<0.05) higher in smokers than in 
non-smokers. Magnesium (Mg) was significantly (p<0.01) reduced in smokers compared to non-smokers. 
Altered Zn status culminating in high Cd:Zn ratio appears the central factor in smokers; leading to oxidative 
stress, DNA damage, mutation, impaired DNA repair, P
53
 expression, angiogenic effect of Cu and impaired 
vitamin A metabolism. These converge in the risk of the carcinogenic process, suggesting high Cd: Zn ratio as 
the critical determinant of the risk of prostate cancer in smokers and possibly a biomarker of susceptibility to 
this environmental disease. 
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Introduction 
Prostate cancer is a major health problem in 
both the industrialized and developing countries. It 
is the most frequently diagnosed male cancer and 
the second most common cause of cancer death 
among men accounting for 29% of all new cases of 
cancer (Jemal et al. 2004; 2007). The etiology of 
human prostate cancer is complex and poorly 
understood however there is evidence that dietary 
factors are involved in the high incidence of 
prostate cancer in the United States and Western 
Europe, implicating environmental or food-derived 
carcinogens in the initiation of prostate 
carcinogenesis (Grover and Martin, 2002)  
Cadmium (Cd) is a substantial constituent of 
cigarette smoke  (Satarug and Moore, 2004) and is 
regarded as a human carcinogen based largely on 
evidence from lung cancers from long-term 
inhalation of cadmium at high exposure levels 
(Feld, 1992; IARC,1993; Bakshi et al,2008)  The 
relationship with prostate cancer is less clear, 
cadmium is also an antagonist of zinc. Although 
the relationship between smoking and cancer of the 
prostate was not clear (Hickney,2001), most 
prospective cohort studies found a positive 
association between current smoking and fatal 
cancer of the prostate (Hsing et al, 1990; Hiatt et 
al, 1994; Rodriguez et al, 1997; Giovanucci et 
al,1999; Plasko et al 2003). 
Zinc is an essential nutrient. Although several 
risk factors have been implicated in the etiology of 
cancer of the prostate, only age, race and family 
history are established risk factors. Similarly, 
though data from previous twin and family studies 
suggest genetic component for prostate cancer 
(Parent and Siemiotycki, 2001) this can be 
modulated by zinc, a significant factor in gene 
expression (Alvanja et al, 2003)  DNA repair 
mechanisms defend against exogenous insults 
which can lead to gene rearrangement, 
translocations, amplifications and deletions which 
in turn contribute to cancer development (Hsing et 
al,2000; Hsing 2001; Pioret and Weston, 2002).
 
Zinc plays a vital role in these repair mechanisms 
through zinc fingers (Berg et al, 1990; Berdanier, 
1998). Zinc and cadmium invariably occur together 
in nature because of their similar chemical 
properties. It has been suggested that even small 
repeated low doses of cadmium could accumulate 




cadmium observed on the prostate (Sancar and 
Tang, 1993). 
Though cadmium has been implicated 
epidemiologically and experimentally in the 
etiology of prostate cancer, there is dearth of data 
on the ratio or relationship between zinc and 
cadmium and its implications for risk of prostate 
cancer in smokers. To clarify the possible role of 
alteration of this normal ratio on DNA repair 
pathways and prostate carcinogenesis we 
investigated active cigarette smokers and non-
smokers and the levels of other related biochemical 
factors including micronutrients. In this report we 
evaluated the individual and combined effects of 
cadmium – zinc ratio as a possible predictive 
biomarker of the risk of prostate cancer in cigarette 
smokers. 
 
Materials and Methods 
The method adopted in this report is largely as 
previously described in our earlier report (Anetor 
and Adeniyi, 2001). In brief 55 apparently healthy 
male active cigarette smokers were selected for the 
study. Their mean age was 33+3.0 (SD; range 22-
59) years. A smoker in this study was defined as 
any subject who smoked at least 4 sticks of 
cigarette per day and smoked consistently for at 
least 3 years. The smokers in this study have been 
smoking for a period ranging 3-45 years (mean 
16+2.0 years). Forty-one (41) non smokers, (non 
passive smokers), mean age 30.0 + 2.0 (SD; range 
18-57) years served as controls. Both smokers and 
controls were on similar dietary intake and resident 
in the same geographical locale. 
Blood Collection 
Ten millitres (10ml) of blood were collected 
with a minimum of stasis using disposable plastic 
syringes and pyrogen free needles (Becton – 
Dickinson and Co Rutherford, NJ), dispensed into 
disposable “SST” brand Vacutainer tubes (Becton-
Dickinson and Co Rutherford NJ). Serum was 
obtained from these tubes after separation 
according to standard methods. All serum samples 
were frozen until time for analysis. 
Biochemical Analyses 
This again is as earlier described in our 
previous paper (Anetor and Adeniyi, 2001).
 
In brief 
cadmium was determined by the modified methods 
of Ediger and Coleman (1973) and Alfaro (1973), a 
modification of the method of Piper and Higgins 
(1967) – using atomic absorption 
spectrophotometry (AAS). Copper was determined 
by the modified method of Alfaro (1973). Zinc was 
determined by the modified methods of Davies et 
al. (1968) and Alfaro (1973). 
All trace metals were determined using model 
403 Perkin-Elmer AAS (Perkin, Elmer, and Oak 
Brook, IL). Clean metal techniques were employed. 
Magnesium was determined with Data Medical 
colorimetric Kit (Data Medical Associate (DMA), 
Texas).  Total proteins and albumin were 
determined by the method of Doumas (1975). Total 
globulin was computed from the difference 
between total proteins and albumin. Calcium was 
determined by the method of Howell et al(1966). 
Total cholesterol was determined by the method of 
Watson et al (1979). Alkaline phosphatase activity 
was determined by the method of Bessy Lowry and 
Brock(1946), serum iron was determined by the 
colorimetric method of Goodwin, Murphy and 
Guillmute(1966), while the assay of potassium was 
conducted using the method of Charlton, Fleming 
and Zipp(1982).  Cd: Zn ratio was obtained by 
dividing the serum cadmium concentration by that 
of the zinc to express the Cd burden per patient, in 
turn reflecting the cellular Cd toxic stress. 
Data Analysis 
Data were analyzed using Hewlett Packard 
computing system, Model Hp-11-c (Hewlet 
Packard Portable computer division, Corvallis, 
USA) and SPSS for windows version 10. Pearson’s 
Correlation Coefficient was used to investigate 
association between Cd and Zn, Cd vs. duration of 
smoking, Cd vs. age, Cu vs. Zn and Cd vs. number 
of sticks smoked. Results were expressed in mean 
+ standard error of mean (SEM). The five percent 
level (P<0.05) of significance was employed to 
determine statistical significance. 
 
Results 
The results are presented in Tables 1 – 4. 
Cadmium was significantly higher in smokers 
compared with non-smokers (p<0.001), the level in 
smokers being three (3) fold than in non-smokers. 
In contrast Zn level was significantly reduced in 
smokers compared with non-smokers (p<0.001). 
Unlike Zn, Cu was significantly higher in smokers 
than in non-smokers (p<0.05). The iron (Fe) level 
in smokers though higher was not significantly 
different (p>0.05). The zinc: cadmium ratio was 
significantly reduced (p<0.001), implying high 
cadmium: zinc ratio. This ratio was four and a half 
(4.5) times the level in non-smokers. Total protein, 
albumin, total globulins and total calcium levels 
were all significantly reduced in smokers compared 
with non-smokers (p<0.001) in all cases. Total 
cholesterol was lower in smokers but not 
significantly so (p>0.05), potassium (k
+
) was 
slightly but significantly higher in smokers than in 
non-smokers (p<0.05). Magnesium (Mg
2+
) was 
also significantly lower in smokers than in non-
smokers (p<0.01). Correlation studies showed 
positive significant association between Zn and 
number of cigarette sticks smoked (r= 0.272, 
p<0.05) and age versus Cu (r= 0.301, p<0.05) age 
versus duration of smoking were strongly 
positively correlated (r= 0.508, p< 0.01). Others 
were not significantly correlated. 
 
 






Table 1: Age of cigarette smokers, numbers of 





Age (Years) 33.0 + 3.0 30.0 + 2.0 
Number of 
sticks 
> 4 for at least 3 years 
Mean duration 
of smoking 
16.0 + 2.0 - 





Table 2: Serum Cd, Zn, Cu, Mg, K
+
 and Fe levels 
in cigarette smokers and non-smokers 












































139+7.0 122+12.7 1.98 > 
0.05 
 
Tables 3:  Serum Calcium, total proteins, albumin, 
total globulins, alkaline phosphatase in  cigarette 


















149 + 6.2 161 + 
8.05 






























Cigarette smoking represents a source of 
substantial exposure to cadmium over a prolonged 
period. Each stick of cigarette contains 1-2 ug of 
cadmium of which about 10% is absorbed by the 
lung. The significantly higher cadmium level found 
in smokers in this report is consistent with earlier 
reports that blood cadmium levels for smokers may 
be up to four times as high as those for non 
smokers (IPCS,1992) and that because of 
cadmium’s extremely long biological half-life, 
even ex-smokers have higher Cd levels than non 
smokers. 
 
Table 4: Pearson’s Correlation studies in cigarette 
 smokers 
.  r                         P 
Duration of 
smoking 
Age 0.508 <0.01 
No. of sticks 
smoked 
Zn 0.272 <0.05 
Age Cu 0.301 <0.05 
Cd Zn 0.045 >0.05 
Cu Zn 0.152 >0.05 





A relationship between cancers of the prostate 
in humans who smoke is unclear inspite of 
suggestive results in rats (Goyer et al.2004). 
Parenteral administration or oral exposure to 
cadmium can result in proliferative lesions and 
tumors of the prostate in rats. The prominent toxic 
effects of cadmium on testicular tissue are well 
recognized. As far back as 1919, Alsberg and 
Schwartz had noted that administration of Cd salts 
to animals caused bluish discoloration of the testes 
(Alsberg and Schwartz, 1919). This early 
observation however escaped further investigation 
for about forty years. In about the mid-1950s 
Parizek (1957)
 
rediscovered and exhaustively 
investigated the destructive effect of Cd on 
testicular tissue. The sterilizing effect of Cd is rapid 
and experimental animals may become 
permanently sterile in as short duration as 24hrs 
post administration (Parizek and Zahor, 
1956;Parizek, 1957). The testes thus seem to be 
extremely sensitive to the toxic effects of Cd; 
hemorrhagic necrosis of rodent testes can be 
induced by Cd concentrations as low as 0.15ug/g 
(Parizek, 1957). 
In contrast the ability of Cd to induce 
neoplasms in the prostate of rats appears typically 
dose related at doses below the threshold for 
significant testicular toxicity (Gunn et al.1968). 
Thus initiation of prostate cancer appears as an 
early event in cancer of the male reproductive 
system. A report by Lemen et al (1975) among 
other forms of cancer in exposure to Cd reported 4 
cases of prostate cancer against 0.88 expected. The 
average age of death was 73 years. This earlier 
report appears to strengthen this and other tenuous 
association between cadmium exposure and the 
incidence of carcinoma of the prostate. Prostate 
cancer is a relatively, slow growing cancer. This 
probably parallels the relatively long half life of 




cadmium and the time it takes for the critical ratio 
between Cd and Zn to be upturned. This is 
probably consistent with the observation by Malins 
et al (2001) that more than 70% of cases of Ca 
prostate are diagnosed over age 65 years, and that 
this is possibly explained by the accumulation of 
mutations and decline in DNA repair during aging. 
The very significantly decreased Zn level in 
smokers appears to confirm the known mutual 
antagonism between zinc and cadmium. (Cotzias et 
al1961; Hill et al 1963; Elsenhans et al 1991; 
Schümann, 1993) One possible explanation for this 
could be due to the established competition 
between Zn and Cd for binding sites on 
metallothionein. This suggests the strong 
possibility therefore, that increase in cadmium level 
diminishes zinc levels in smokers. It is also 
possible that this arises because of the competition 
for common metabolic pathways by Cd and Zn. 
This observed depression of zinc has far reaching 
implications for cellular activities and genomic 
stability and by extension for the pathogenesis of 
prostate cancer. Zinc is central to DNA repair 
pathways, perturbation of which may be involved 
in prostate cancer etiology. The positive correlation 
between number of sticks of cigarette smoked may 
be an attempt by the body to increase Zn level 
though insufficient. This appears to allude to the 
critical role of zinc. Genomic stability and integrity 
are important in maintaining accurate DNA 
replication (Hill et al1963; Berwick and Vineis, 
2000). Cadmium alters the fidelity of DNA 
replication (William et al, 2000), DNA disruptions 
leads to gene rearrangements, translocations, 
amplifications and deletions which can contribute 
to cancer development (Hsing et al, 2000; Hsing, 
2001; Pioriet and Weston, 2002). 
Another mechanism by which Cd may 
participate in the prostate carcinogenic process is 
by oxidative stress and attendant oxidative injury. 
Cadmium is associated with increased generation 
of reactive oxygen species (ROS) (Ho et al, 2003). 
Zinc reverses oxidative damage as a constituent of 
cytotoxic copper-zinc superoxide dismutase (Cu-
Zn SOD) (Valle and Falchuk, 1993). The decreased 
Zn level may be permissive to DNA oxidative 
damage which can lead to mutation. Mutation is an 
important phenomenon in cancers of many sites 
(Clayson, 2001). 
The observed reduced zinc level also appears in 
line with the hypothesis of Levander and Cheng 
(1980) and Mills (1981)
 
who stated that an 
overabundance of one trace element can interfere 
with the level and metabolic utilization of another 
element present in normal or marginal 
concentrations. This is very important owing to the 
fundamental role of zinc in DNA and protein 
synthesis and metabolism (Prasad, 1993). The role 
of zinc in the very fundamental biologic process of 
protein synthesis is so fundamental that Golden and 
Golden (1981) have compared it to an essential 
amino acid. Proteins are required as regulatory 
factors which in turn regulate cell cycle which 
when impaired can lead to the carcinogenic process 
in the prostate; one of the sites with the highest 
concentration of zinc in the human body(Kerr, 
1964). Cancer is essentially a consequence of 
disordered genome function. Thus zinc induced 
genomic instability may contribute to prostate 
carcinogenesis. 
Although well recognized that insulin, lowers 
blood glucose level, in reality, it has a wide-
ranging effects not only on glucose metabolism but 
also on potassium homeostasis; cell volume, cell 
growth and differentiation (1999). Interestingly, the 
multiple effects of insulin are expressed through a 
single type of insulin receptor; many of the insulin 
signaling protein are involved in the normal control 
of cell growth and differentiation. Insulin is Zn 
dependent. In carcinogenesis, where there is 
abnormal cell growth and differentiation, this is 
often due to production of abnormal proteins by 
tumor – causing genes, oncogenes. This can arise 
from alteration in Zn status. 
Apart from insulin being a zinc dependent 
hormone it plays a significant role in gene 
expression which may be impaired by the high Cd: 
Zn ratio and reduce bioavailability of zinc. 
Zinc is essential for prostate function (Kerr, 
1960) and it has been shown that Zinc deficiency 
results in increased oxidative DNA damage and 
disruption of the p53 tumour suppressor protein 
(Ho et al, 2003). Though men with very high intake 
of supplemental zinc had a significant two-fold 
increased risk of prostate cancer (Krone et al, 
2001), this is probably due to contamination of Zn 
supplement with Cd (Krone et al, 2001). Cadmium 
is a very common contaminant of zinc as they 
occur in the same ore (IPCS, 1992). 
The pathogenesis of Cadmium associated 
prostate carcinogenesis might include aberrant gene 
expression resulting in stimulation of Prostatic Cell 
proliferation or blockage of apoptosis and 
activation of transcription factors such as 
metallothionein genes and activation of some 
proto-oncogenes. All at least in part resulting from 
reduced Zinc which may enhance disordered cell 
proliferation with damaged DNA (Kerr, 1960; 
Sandstead, 1976; Salway, 1999; Goyer et al, 2004). 
Suppression of DNA repair owing to the aberrant 
zinc: cadmium ratio would be additive to the 
population of cells with DNA damage. This may 
further be accentuated by disruption of p53 as a 
result of zinc deficiency. Cadmium has been shown 
to replace zinc in the tumor suppressor protein p53 
(Meplan et al, 1999), thereby impairing p53’s DNA 
binding activity. This impairment can decrease the 
ability of cell to respond to DNA damage; 
impairing repair processes. 




The p53 protein is a remarkable protein that is 
involved in diverse cell functions including 
detection of DNA damage, the regulation of cell 
cycle progression and the induction of apoptosis. 
The p53 gene and the protein it encodes has been 
aptly called the “guardian of the genome (Lane, 
1992) in recognition of the critical role it plays in 
the life and death of cells. The p53 gene encodes a 
53-KD nuclear phospho-protein that is active in 
regulating the transcription of a number of genes 
relating to cell cycle progression and apoptosis. 
Attenuation of apoptosis and accelerated tumor 
growth correlates with loss of p53, which can occur 
with replacement of Zn by cadmium in the tumor 
suppressor protein, p53; thereby impairing 
recognition of DNA damage, repair mechanisms 
and genome stability. This will ultimately favor 
accumulation of multiple genetic changes 
characteristic of development of prostate neoplasia. 
This suggests that loss of p53-mediated apoptosis 
secondary to altered cadmium: zinc ratio may be a 
rate limiting step in prostate tissue tumorigenesis. 
The p53 gene and its protein play an important 
role by recognizing DNA damage triggering repair 
and apoptosis and inducing cell cycle arrest. It 
maintains genome stability and prevents 
accumulation of multiple genetic changes 
characteristics of development of Carcinogenesis.  
The reduced total globulin level may indirectly 
allude to the reduction in this protein among others. 
Epithelial carcinogenesis is a multistep process in 
which an accumulation of genetic events within a 
single cell line leads to a progressively dysplastic 
cellular architecture, deregulated cell growth and 
finally carcinoma. Apart from the possible direct 
involvement of zinc in the accumulated genetic 
events, Zn may also be indirectly involved in 
epithelial carcinogenesis through its regulation of 
Vitamin A metabolism. (Smith et al, 1973) 
Vitamin A is a retinoid which binds to nuclear 
retinoid receptors, the activation of which results in 
changes that include controlling cell differentiation. 
Retinoids, including vitamin A have anti-cancer 
properties which may reflect their ability to induce 
differentiation (Brietman et al, 1980; Bollag and 
Holdener, 1992). But the bioavailability and 
utilization of vitamin A depends on adequate zinc 
status (Smith et al, 1973), underscoring the pivotal 
role Zn plays in cellular processes and the 
pathologic significance of alteration in its status. 
Indeed the toxicity of cadmium is so dependent on 
the disturbance of zinc metabolism, leading to the 
description of cadmium as an antimetabolite of 
Zinc (Vigliani, 1969). This seemed to have been 
hitherto unrecognized in discussion of cigarette 
smoking and risk of Ca prostate. 
Besides, the significantly reduced Zn per se, the 
high Cd: Zn or low Zn:Cd ratio in comparison to 
non-smokers implies that cellular cadmium burden 
is substantial. This indicates significantly reduced 
level of Zn relative to Cd, thus suggestive of the 
loss or significant inhibition of the overriding 
protective effect of Zn on cadmium toxicity 
(Parizek, 1957) leading to a raised Cd burden in a 
given cellular unit and in turn the intensity or 
enhancing its effect on cellular processes. This may 
at least in part increase the risk of the potential of 
development of proliferative lesion in the prostate 
of smokers probably concomitant with the greater 
genome instability. This appears consistent with the 
very recent observation of Goyer, Liu and Waalkes 
(2004) that the pathogenesis of prostatic cancer 
(carcinogenesis) might include aberrant gene 
expression resulting in stimulation of cell 
proliferation or inhibition of apoptosis. Suppression 
of DNA repair secondary to reduced Zn would add 
to the population of cells with damaged DNA. Thus 
one consequence of the high cadmium:zinc ratio 
may be the high error rate and lack of efficient 
DNA repair systems leading to high mutation rate 
leading to prostate carcinogenesis. 
The ratio of zinc to cadmium concentrations has 
been so important in some other pathologies that 
whether an industrial worker is susceptible to 
hypertension and or coronary heart disease is 
determined by this ratio (Bosquet, 1979). This has 
however not been extended to cadmium associated 
prostatic carcinogenesis. Zinc can sometimes be 
displaced on the zinc fingers by other divalent 
metals. Iron, for example has been used to displace 
zinc on the DNA binding protein that also binds 
estrogen (Yoko and Alcock, 1994). This protein 
binds to the estrogen response element of the DNA 
in the promoter regions encoding estrogen 
responsive gene products. When this occurs in the 
presence of H2O2 and ascorbic acid, damage to the 
proximate DNA, the estrogen response element 
occurs. It has been suggested in this circumstance 
of an iron substituted zinc finger that free radicals 
are more readily generated with consequences of 
genomic damage (Conte et al, 1996). This 
suggestion has been offered as an explanation of 
how excess iron (iron toxicity) could initiate the 
cellular changes that occur in carcinogenesis. 
Similarly, in excess cadmium it can also substitute 
for zinc in zinc fingers. In this substitution the 
resultant fingers are nonfunctional, impair DNA 
repair and function. 
The alteration in Zn status may be particularly 
relevant to developing countries. Although the 
prevalence of Zn deficiency is uncertain globally 
(Sandstead, 1991) it appears commoner among 
populations of developing countries (Gibson, 1994) 
where smoking is also on the increase (Anetor and 
Adeniyi,2001) while it is on the decline in the 
developed world. A deficiency of Zn ranks among 
the top ten leading causes of death in developing 
countries (WHO, 2002). This may be accentuated 
by the poor recognition of the importance of zinc 
(Sandstead and Alcock, 1997; WHO, 2002). 





The significantly elevated copper level (may 
arise from the antagonism between Cu and Zn) 
though previously thought to be a protective 
response against cadmium toxicity may indeed 
favor prostate angiogenesis (Brewer, 2000), which 
favors cancer or tumor growth. The relationship of 
copper is not causative but associative; cancer cells 
proliferate in a high copper environment but in low 
copper environment cancer cells would remain 
dormant or grow slowly, increasing survival time 
of patients (Brewer, 2000). Thus the increase in 
copper level in part probably arising from the 
abolishing of the competitive inhibition of Cu 
absorption by Zn in the intestine (Evans, 1970; 
Shank and Vetter, 1974) may be another pathway 
by which alteration in zinc metabolism contributes 
to the risk of Ca prostate. 
Whatever the mechanism, one biologic 
implication of these findings is that high cadmium-  
zinc ratio may be permissive to malignant 
proliferation of prostate cells and this relationship 
may serve as a predictive biomarker of the risk of 
prostate cancer in cigarette smokers. This appears 
consistent with the suggestion that cadmium 
increases the risk for prostate cancer by interacting 
with Zinc (Achanzar et al, 2001). Zinc is a critical 
micronutrient in multiple intracellular metabolic 
pathways, and the prostate contains high 
concentrations of zinc (Golden and Golden, 1981). 
Several enzymes involved in the replication of 
DNA and RNA, such as polymerases, require zinc 
to function optimally (Golden and Golden, 1981; 
Prasad, 1993). The prostate has the highest 
concentration of zinc of any organ of the body; 
probably reflecting the critical role it plays in 
prostate health.  
Cancerous prostate glands have been shown to 
have lower level of zinc than do non cancerous 
gland (Schrodt, 1964; Brys et al, 1997). Though it 
remains unclear whether zinc is associated with 
prostate cancer, the current study suggests that it 
may be a prime candidate as a predictive biomarker 
of the risk of prostate cancer in cigarette smokers. 
This appears to corroborate the observations which 
suggested higher risk in smokers with increased 
exposure to cadmium (Rodriguez, 1997, 
Grovanucci et al, 1999; Hickney et al, 2001). 
Increase Cd has been shown to cause dose-
dependent proliferative precancerous lesions in a 
segment of the prostate (Plankson et al, 2003; 
Bakshi et al, 2008). 
Some studies have also shown an increased 
concentration of cadmium in prostates with cancer 
compare to normal glands (Lindegaard et al, 1990; 
Waalkes et al, 1997; Waalkes et al, 1999).  This is 
indirectly consistent with the findings; in this study 
in that increased plasma Cd concentration will 
ultimately increase prostatic tissue concentration 
and owing to the mutual antagonism between both 
elements, displace Zn. The induced Zn deficiency 
can lead to DNA disorders (Castro, 1992). The 
altered Zn status may also alter Calcium status 
(Emery and O’Dell, 1993). Zinc deficiency results 
in an impaired calcium uptake probably due to a 
decreased synthesis of intestinal calbindin.Calcium 
plays a crucial role in cell signaling, impairment of 
which might also contribute to the carcinogenic 
process. The low Mg level may also play a role in 
this (Rilvin, 1994). 
Though at present there is lack of agreement on 
the role of cadmium on prostate cancer in cigarette 
smokers, alteration of Zn status especially a high 
ratio of Cd: Zn may be a critical factor but this has 
not been previously explored. It may however 
serve as a simple reliable predictive biomarker of 
the risk of cancer of the prostate in smokers. This 
study appears to provide evidence to show that the 
convergence of: reduced Zn level, high Cd: Zn 
ratio, increased Cu level, decreased total globulin  
may serve as a simple panel of biomarkers of risk 
of prostate cancer.  
This appears reasonably consistent with the 
conclusion of Kok et al (1988) who examined 
serum Cu and Zn levels and risk of death from 
Cancer and Cardiovascular disease level may 
greatly increase genome instability and permissive 
to prostate epithelial proliferation that may 
culminate in cancer. The reduced cholesterol level 
in smokers though not significantly may be 
instructive, in that they normally carry elevated 
cholesterol level. It is not clear if this is a trend 
consistent with onset of neoplasia; low cholesterol, 
triglycerides, albumin and prealbumin are among 
indices suggestive of altered metabolic state in 
neoplastic related events owing to wasting. 
Wasting may be induced by tumor necrotic factor 
(TNF), probably a response to initiation of 
neoplasia or stressful stimuli (Sacher and 
McPherson, 2000). Thus their combination may 
constitute a useful panel of biomarker that may be 
predictive of the risk of cadmium associated 
carcinoma of the prostate in smokers. If confirmed 
such easily accessible panel could serve as 
surrogate end points for the early detection of 
prostate cancer risk and improve prevention, 
management and prognosis. The report of Drasch 
et al (2005) on selenium cadmium ratio in deceased 
prostate cancer patients may be a corroboration of 
the critical role of the ratio of cadmium to zinc and 
in the genomic activities including stability in the 
prostate. Though these investigators have 
suggested that the associated physiological 
alteration of selenium / cadmium ratio could 
elevate the increased cancer risk in smokers, this 
may even be truer of zinc as it is more abundant 
and important in the prostate.  
Further studies involving actual cases of 
smokers who developed prostate cancer is 
recommended to assess in depth the molecular 
basis of interaction between Cd and Zn and other 





related disturbances which may be crucial to an 
improved understanding of the basis of prostate 
cancer in cigarette smokers and development of 
reliable panel of biomarkers that will be readily 
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